Advancing cancer care and innovation.
The QEII Foundation has a long-standing history of supporting cancer care priorities at the QEII, funding lifesaving clinics, equipment, treatment advancements and research – helping to transform the delivery of care for the one in two Atlantic Canadians who will receive a cancer diagnosis in their lifetime.
From radiation treatment to surgery and systemic therapy, the QEII stands on guard for Atlantic Canadian patients and their families when they need it most – providing the full spectrum of care and personalized treatments.
More than 2,300 QEII Foundation donors came together to fund surgical robotics technology, the most effective treatment for some cancers. Together they raised $8.1 million, supporting those living with prostate, kidney, gynecologic and ENT (ear, nose and throat) cancers.
Donors also brought a best-in-the-world detection tool for neuroendocrine cancers to the QEII in 2021, a game-changer for patients like Sharon Needham.